TAMMY CORNELIUS: Open Payments
NPI 1366765232 · EVA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,461 in 84 payments from 21 companies in 2025. Trend: 2023 $770 · 2024 $1,285 · 2025 $1,461
Food & beverage: $1,461
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $255 |
| AstraZeneca Pharmaceuticals LP | 10 | $201 |
| Novo Nordisk Inc | 10 | $172 |
| Medtronic, Inc. | 15 | $171 |
| Lilly USA, LLC | 4 | $77 |
| Amgen Inc. | 4 | $76 |
| Exact Sciences Corporation | 3 | $65 |
| PFIZER INC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Eisai Inc. | 2 | $40 |
Products named: MINIMED 780G, VRAYLAR, Ozempic, FARXIGA, VENCLEXTA, REXULTI, BREZTRI, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
